Clodronic acid
MUSCULO-SKELETAL SYSTEM
Also known as: clodronate, dichloromethylenediphosphonic acid, methanedichlorodiphosphonic acid
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Clodronic acid is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1986. DrugCentral lists 6 molecular targets, including traI, SLC17A9 and SLC25A5.
- Molecular targets: traI, SLC17A9, SLC25A5 and SLC25A4 (6 listed in DrugCentral).
- ATC code: M05BA02 (Bisphosphonates).
- Molecular formula: CH4Cl2O6P2; molecular weight 244.88 g/mol.
Mechanism & targets
Molecular targets (6)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Type IV secretion-like conjugative transfer relaxase protein TraI | traI | unknown | Ki 8.52 |
| Solute carrier family 17 member 9 | SLC17A9 | inhibitor | IC50 7.81 |
| ADP/ATP translocase 2 | SLC25A5 | unknown | — |
| ADP/ATP translocase 1 | SLC25A4 | unknown | — |
| ADP/ATP translocase 3 | SLC25A6 | unknown | — |
| Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | unknown | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1986-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
M05BA02 | MUSCULO-SKELETAL SYSTEM › DRUGS FOR TREATMENT OF BONE DISEASES › DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION › Bisphosphonates |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Osteonecrosis of jaw | 129.2 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Clodronic acid is on its molecule page.
| Molecular formula | CH4Cl2O6P2 |
|---|---|
| Molecular weight | 244.88 g/mol |
| CAS number | 10596-23-3 |
| InChIKey | ACSIXWWBWUQEHA-UHFFFAOYSA-N |
| PubChem CID | 25419 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Clodronic acid work?
Its molecular targets in DrugCentral include traI, SLC17A9 (inhibitor), SLC25A5 and SLC25A4.
When was Clodronic acid first approved?
Clodronic acid was first approved by the YEAR INTRODUCED in 1986.
What is the chemical formula of Clodronic acid?
Clodronic acid has the molecular formula CH4Cl2O6P2 and a molecular weight of 244.88 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 690 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL12318 — compound record and bioactivity
- PubChem CID 25419 — chemical identifiers
- DrugBank DB00720 — drug record
- FDA UNII 0813BZ6866 — substance identity
- UniProt Q9BYT1 (SLC17A9) — target protein
- UniProt P05141 (SLC25A5) — target protein
- UniProt P12235 (SLC25A4) — target protein
- UniProt P12236 (SLC25A6) — target protein
- UniProt P18031 (PTPN1) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.